Holding(s) in Company

Summary by AI BETAClose X

On August 27, 2025, Genflow Biosciences PLC announced that Jonathan Mark Swann crossed a threshold related to voting rights on August 26, 2025. Swann's total voting rights attached to shares in the issuer increased to 7.01%, representing 31,788,550 voting rights. This is an increase from the previously notified position of 6.01%, which represented 21,025,000 voting rights. The 31,788,550 voting rights are direct, with zero indirect voting rights or voting rights through financial instruments.

Disclaimer*

UK 100

Latest directors dealings